AU Patent

AU2023352588A1 — Microparticle formulations for intravenous therapy and methods for their manufacture and use

Assigned to Methodist Hospital · Expires 2025-04-03 · 1y expired

What this patent protects

The present disclosure provides methods and formulations for therapeutic microparticles, wherein formulations are used for administering therapeutic microparticles to subjects by way of intravenous injection. Also, provided are methods of administering therapeutic microparticles …

USPTO Abstract

The present disclosure provides methods and formulations for therapeutic microparticles, wherein formulations are used for administering therapeutic microparticles to subjects by way of intravenous injection. Also, provided are methods of administering therapeutic microparticles to subjects in need thereof. The formulations provide stability and prevent settling and clumping of therapeutic microparticles in solution up to 3 hours.

Drugs covered by this patent

Patent Metadata

Patent number
AU2023352588A1
Jurisdiction
AU
Classification
—
Expires
2025-04-03
Drug substance claim
No
Drug product claim
No
Assignee
Methodist Hospital
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.